To support BOPA members managing the introduction of biosimilar rituximab, a paper has been published on the members documents section of website which BOPA members can use in their own hospital to support rapid infusion of biosimilar rituximab
There is also details of an accompanying audit.
See http://www.bopawebsite.org/publications/members-documents
The popular Introduction to Cancer Course is coming to to Glasgow in March 2026 The BOPA Introduction to Cancer Course 2026 WHEN: Thursday 26th & Friday 27th March 2026 WHERE: The…
The 2026 PRUK funding round launched on 24th November 2025 and will close at 1pm on 25th March 2026. BOPA-PRUK Research Award – NOW OPEN for Applications 2026 This award provides pharmacy professionals…
The Research Subcommittee would like to invite members to participate in this MPharm research project. Please find further details below. I am a 4th year pharmacy student at Kingston University…
Dear Colleagues, The University of Birmingham and University Hospitals Birmingham are jointly conducting a project exploring staff perceptions around the challenges of implementing NICE Technology Appraisal Guidance (TAGs) in Cancer Services. We…
The 29th BOPA Annual Conference in 2026 will be held at the ICC London Olympia on 2-4 October 2026.
Check out the latest information here: Latest Conference 2026 – BOPA
Everything you need to know
